Physician profile
Peter A Bryce
NPI 1255493110
$529.86
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.44 · 2020: $75.95 · 2021: $143 · 2022: $215.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $176.00 | 2022 | |
| Merck Sharp & Dohme LLC | $107.91 | 2019-2021 | |
| Organon LLC | $59.91 | 2021-2022 | |
| Abbvie INC. | $44.06 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $42.89 | 2020-2021 | |
| Baxter Healthcare | $31.80 | 2021 | |
| Roche Diagnostics Corporation | $21.39 | 2019 | |
| Allergan, INC. | $18.89 | 2022 | |
| Hologic Sales and Service, LLC | $14.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bryce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.